The Gastrointestinal OTC Drugs Market to grow by USD 4,759.86 million from 2022 to 2027|Increase in the prevalence of gastrointestinal disorders to boost the market- Technavio

NEW YORK, July 25, 2023 /PRNewswire/ -- The gastrointestinal OTC drugs market size is estimated to grow by USD 4,759.86 million from 2022 to 2027, according to Technavio. The market is estimated to grow at a CAGR of 5.29% during the forecast period. However, the growth momentum will be progressing. For more insights on the historical (2017 to 2021) and forecast market size (2023 to 2027) - Request a sample report

What's New?

• Special coverage on the Russia-Ukraine war; global inflation; recovery analysis from COVID-19; supply chain disruptions, global trade tensions; and risk of recession 
• Global competitiveness and key competitor positions 
• Market presence across multiple geographical footprints - Strong/Active/Niche/Trivial  - buy the report!

Gastrointestinal OTC Drugs Market - Segmentation Assessment
Segment Overview
Technavio has segmented the market based on product (antacids, laxatives, anti-diarrheal, anti-emetics, and others), distribution channel (offline and online)

• The market share growth by the antacid segment will be significant during the forecast period. Antacids are used to treat heartburn, indigestion, and acid reflux symptoms due to an increase in stomach acidity. The prevalence of gastrointestinal problems is expanding, due to various factors such as unhealthy eating habits, stressful lifestyles, and the utilization of non-steroidal anti-inflammatory drugs (NSAIDs) which is driving the requirement for antacid products. Hence, these benefits are expected to drive segment growth during the forecast period.

Geography Overview
By geography, the global gastrointestinal OTC drugs market is segmented into North America, Europe, Asia, and the Rest of the World (ROW). The report provides actionable insights and estimates the contribution of all regions to the growth of the gastrointestinal OTC drugs market.

• North America held the largest share of the global market in 2022, and the market in the region is estimated to witness an incremental growth of 40%. This is because of the rising geriatric populace in North America leading to a rise in the demand for gastrointestinal OTC medications. The presence of cutting-edge medical services infrastructure and major pharmaceutical companies are also contributing to the increased product demand in the region. Hence, these factors are expected to drive market growth in the region during the forecast period.

Insights on the market contribution of various segments, including country and region wise historic data (2017 to 2021), and forecast market size (2023 to 2027) - Download a Sample Report

Gastrointestinal OTC Drugs Market – Market Dynamics
Key Drivers

The increase in the prevalence of gastrointestinal disorders is a key factor driving the market growth. This is resulting in increased healthcare costs and decreases the quality of life of people. The primary causes of these disorders are changing lifestyles and eating habits of people. Another cause of gastrointestinal disorders is the consumption of processed and fast food. This disorder can cause chronic pain, loss of appetite, and reduced quality of life. Hence, these factors will drive the market growth during the forecast period.

Major Trends

The increase in the adoption of online platforms is a major trend in the market. The popularity of online platforms has expanded as they offer comfort, availability, and different choices to purchasers. Buyers can make more informed choices because these platforms provide comprehensive information about each drug, including its components, dosage, and potential side effects. For instance, Amazon offers many gastrointestinal OTC medications, like antacids, laxatives, and anti-diarrhea medications, that can be delivered within a day to the customer. Hence, the rising adoption of online platforms will drive market growth during the forecast period.

Significant Challenges

The risk of taking the wrong medication due to incorrect self-diagnosis is a significant challenge restricting market growth. It's possible that patients lack the expertise or knowledge necessary to distinguish between various gastrointestinal conditions. This can lead to undesirable side effects, delayed inconveniences, and serious complexities. Additionally, patients may not know about the utilization of specific OTC gastrointestinal medications, which can further lead to risky medication connections or antagonistic impacts. Hence, these factors are expected to restrict drive market growth during the forecast period.

Insights on Market Drivers, trends, & Challenges, historic period(2017 to 2021), and forecast period(2023 to 2027)- Request a sample report!

What are the key data covered in this Gastrointestinal OTC Drugs Market report?

• CAGR of the market during the forecast period
• Detailed information on factors that will drive the growth of the gastrointestinal OTC drugs market between 2023 and 2027
• Precise estimation of the size of the gastrointestinal OTC drugs market and its contribution to the market in focus on the parent market
• Accurate predictions about upcoming trends and changes in consumer behavior
• Growth of the gastrointestinal OTC drugs market across North America, Europe, Asia, and the Rest of the World (ROW)
• A thorough analysis of the market's competitive landscape and detailed information about vendors
• Comprehensive analysis of factors that will challenge the growth of gastrointestinal OTC drugs market vendors

Gain instant access to 17,000+ market research reports. 

Technavio SUBSCRIPTION platform

Related Reports:

The oncology drugs market size is estimated to grow at a CAGR of 11.99% between 2023 and 2027. The market size is forecast to increase by USD 151.84 billion. Furthermore, this report extensively covers market segmentation by therapy (targeted therapy, immunotherapy, hormonal therapy, and chemotherapy), distribution channel (offline and online), and geography (North America, Europe, Asia, and the Rest of the World (ROW)). The Increasing prevalence of cancer globally is a key factor driving the market growth during the forecast period.

The over-the-counter drug market size is estimated to grow at a CAGR of 6.53% between 2022 and 2027. The market size is forecast to increase by USD 58.54 billion. Furthermore, this report extensively covers market segmentation by route of administration (oral, topical, parenteral, and others), distribution channel (offline and online), and geography (North America, Europe, Asia, and the Rest of the World (ROW)). The new product launches in the global over-the-counter drug market is a key factor driving the market growth during the forecast period.

Table of Contents

1 Executive Summary

• 1.1 Market overview
• Exhibit 01: Executive Summary – Chart on Market Overview
• Exhibit 02: Executive Summary – Data Table on Market Overview
• Exhibit 03: Executive Summary – Chart on Global Market Characteristics
• Exhibit 04: Executive Summary – Chart on Market by Geography
• Exhibit 05: Executive Summary – Chart on Market Segmentation by Product
• Exhibit 06: Executive Summary – Chart on Market Segmentation by Distribution Channel
• Exhibit 07: Executive Summary – Chart on Incremental Growth
• Exhibit 08: Executive Summary – Data Table on Incremental Growth
• Exhibit 09: Executive Summary – Chart on Vendor Market Positioning

2 Market Landscape

• 2.1 Market ecosystem
• Exhibit 10: Parent market
• Exhibit 11: Market Characteristics

3 Market Sizing

• 3.1 Market definition
• Exhibit 12: Offerings of vendors included in the market definition

• 3.2 Market segment analysis 
• Exhibit 13: Market segments

• 3.3 Market size 2022

• 3.4 Market outlook: Forecast for 2022-2027 
• Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
• Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
• Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
• Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)

4 Historic Market Size

• 4.1 Global gastrointestinal OTC drugs market 2017 - 2021 
• Exhibit 18: Historic Market Size – Data Table on global gastrointestinal otc drugs market 2017 - 2021 ($ million)

• 4.2 Product Segment Analysis 2017 - 2021 
• Exhibit 19: Historic Market Size – Product Segment 2017 - 2021 ($ million)

• 4.3 Distribution Channel Segment Analysis 2017 - 2021 
• Exhibit 20: Historic Market Size – Distribution Channel Segment 2017 - 2021 ($ million)

• 4.4 Geography Segment Analysis 2017 - 2021 
• Exhibit 21: Historic Market Size – Geography Segment 2017 - 2021 ($ million)

• 4.5 Country Segment Analysis 2017 - 2021 
• Exhibit 22: Historic Market Size – Country Segment 2017 - 2021 ($ million)

5 Five Forces Analysis

• 5.1 Five forces summary
• Exhibit 23: Five forces analysis - Comparison between 2022 and 2027

• 5.2 Bargaining power of buyers 
• Exhibit 24: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027

• 5.3 Bargaining power of suppliers 
• Exhibit 25: Bargaining power of suppliers – Impact of key factors in 2022 and 2027

• 5.4 Threat of new entrants 
• Exhibit 26: Threat of new entrants – Impact of key factors in 2022 and 2027

• 5.5 Threat of substitutes 
• Exhibit 27: Threat of substitutes – Impact of key factors in 2022 and 2027

• 5.6 Threat of rivalry
• Exhibit 28: Threat of rivalry – Impact of key factors in 2022 and 2027

• 5.7 Market condition
• Exhibit 29: Chart on Market condition - Five forces 2022 and 2027

6 Market Segmentation by Product

• 6.1 Market segments
• Exhibit 30: Chart on Product - Market share 2022-2027 (%)
• Exhibit 31: Data Table on Product - Market share 2022-2027 (%)

• 6.2 Comparison by Product 
• Exhibit 32: Chart on Comparison by Product
• Exhibit 33: Data Table on Comparison by Product

• 6.3 Antacid - Market size and forecast 2022-2027 
• Exhibit 34: Chart on Antacid - Market size and forecast 2022-2027 ($ million)
• Exhibit 35: Data Table on Antacid - Market size and forecast 2022-2027 ($ million)
• Exhibit 36: Chart on Antacid - Year-over-year growth 2022-2027 (%)
• Exhibit 37: Data Table on Antacid - Year-over-year growth 2022-2027 (%)

• 6.4 Laxatives - Market size and forecast 2022-2027 
• Exhibit 38: Chart on Laxatives - Market size and forecast 2022-2027 ($ million)
• Exhibit 39: Data Table on Laxatives - Market size and forecast 2022-2027 ($ million)
• Exhibit 40: Chart on Laxatives - Year-over-year growth 2022-2027 (%)
• Exhibit 41: Data Table on Laxatives - Year-over-year growth 2022-2027 (%)

• 6.5 Anti-diarrheal - Market size and forecast 2022-2027 
• Exhibit 42: Chart on Anti-diarrheal - Market size and forecast 2022-2027 ($ million)
• Exhibit 43: Data Table on Anti-diarrheal - Market size and forecast 2022-2027 ($ million)
• Exhibit 44: Chart on Anti-diarrheal - Year-over-year growth 2022-2027 (%)
• Exhibit 45: Data Table on Anti-diarrheal - Year-over-year growth 2022-2027 (%)

• 6.6 Anti-emetics - Market size and forecast 2022-2027 
• Exhibit 46: Chart on Anti-emetics - Market size and forecast 2022-2027 ($ million)
• Exhibit 47: Data Table on Anti-emetics - Market size and forecast 2022-2027 ($ million)
• Exhibit 48: Chart on Anti-emetics - Year-over-year growth 2022-2027 (%)
• Exhibit 49: Data Table on Anti-emetics - Year-over-year growth 2022-2027 (%)

• 6.7 Others - Market size and forecast 2022-2027 
• Exhibit 50: Chart on Others - Market size and forecast 2022-2027 ($ million)
• Exhibit 51: Data Table on Others - Market size and forecast 2022-2027 ($ million)
• Exhibit 52: Chart on Others - Year-over-year growth 2022-2027 (%)
• Exhibit 53: Data Table on Others - Year-over-year growth 2022-2027 (%)

• 6.8 Market opportunity by Product 
• Exhibit 54: Market opportunity by Product ($ million)
• Exhibit 55: Data Table on Market opportunity by Product ($ million)

7 Market Segmentation by Distribution Channel

• 7.1 Market segments
• Exhibit 56: Chart on Distribution Channel - Market share 2022-2027 (%)
• Exhibit 57: Data Table on Distribution Channel - Market share 2022-2027 (%)

• 7.2 Comparison by Distribution Channel 
• Exhibit 58: Chart on Comparison by Distribution Channel
• Exhibit 59: Data Table on Comparison by Distribution Channel

• 7.3 Offline - Market size and forecast 2022-2027 
• Exhibit 60: Chart on Offline - Market size and forecast 2022-2027 ($ million)
• Exhibit 61: Data Table on Offline - Market size and forecast 2022-2027 ($ million)
• Exhibit 62: Chart on Offline - Year-over-year growth 2022-2027 (%)
• Exhibit 63: Data Table on Offline - Year-over-year growth 2022-2027 (%)

• 7.4 Online - Market size and forecast 2022-2027 
• Exhibit 64: Chart on Online - Market size and forecast 2022-2027 ($ million)
• Exhibit 65: Data Table on Online - Market size and forecast 2022-2027 ($ million)
• Exhibit 66: Chart on Online - Year-over-year growth 2022-2027 (%)
• Exhibit 67: Data Table on Online - Year-over-year growth 2022-2027 (%)

• 7.5 Market opportunity by Distribution Channel 
• Exhibit 68: Market opportunity by Distribution Channel ($ million)
• Exhibit 69: Data Table on Market opportunity by Distribution Channel ($ million)

8 Customer Landscape

• 8.1 Customer landscape overview 
• Exhibit 70: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

• 9.1 Geographic segmentation 
• Exhibit 71: Chart on Market share by geography 2022-2027 (%)
• Exhibit 72: Data Table on Market share by geography 2022-2027 (%)

• 9.2 Geographic comparison 
• Exhibit 73: Chart on Geographic comparison
• Exhibit 74: Data Table on Geographic comparison

• 9.3 North America - Market size and forecast 2022-2027 
• Exhibit 75: Chart on North America - Market size and forecast 2022-2027 ($ million)
• Exhibit 76: Data Table on North America - Market size and forecast 2022-2027 ($ million)
• Exhibit 77: Chart on North America - Year-over-year growth 2022-2027 (%)
• Exhibit 78: Data Table on North America - Year-over-year growth 2022-2027 (%)

• 9.4 Europe - Market size and forecast 2022-2027 
• Exhibit 79: Chart on Europe - Market size and forecast 2022-2027 ($ million)
• Exhibit 80: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
• Exhibit 81: Chart on Europe - Year-over-year growth 2022-2027 (%)
• Exhibit 82: Data Table on Europe - Year-over-year growth 2022-2027 (%)

• 9.5 Asia - Market size and forecast 2022-2027 
• Exhibit 83: Chart on Asia - Market size and forecast 2022-2027 ($ million)
• Exhibit 84: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
• Exhibit 85: Chart on Asia - Year-over-year growth 2022-2027 (%)
• Exhibit 86: Data Table on Asia - Year-over-year growth 2022-2027 (%)

• 9.6 Rest of World (ROW) - Market size and forecast 2022-2027 
• Exhibit 87: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
• Exhibit 88: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
• Exhibit 89: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
• Exhibit 90: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)

• 9.7 US - Market size and forecast 2022-2027 
• Exhibit 91: Chart on US - Market size and forecast 2022-2027 ($ million)
• Exhibit 92: Data Table on US - Market size and forecast 2022-2027 ($ million)
• Exhibit 93: Chart on US - Year-over-year growth 2022-2027 (%)
• Exhibit 94: Data Table on US - Year-over-year growth 2022-2027 (%)

• 9.8 China - Market size and forecast 2022-2027 
• Exhibit 95: Chart on China - Market size and forecast 2022-2027 ($ million)
• Exhibit 96: Data Table on China - Market size and forecast 2022-2027 ($ million)
• Exhibit 97: Chart on China - Year-over-year growth 2022-2027 (%)
• Exhibit 98: Data Table on China - Year-over-year growth 2022-2027 (%)

• 9.9 Japan - Market size and forecast 2022-2027 
• Exhibit 99: Chart on Japan - Market size and forecast 2022-2027 ($ million)
• Exhibit 100: Data Table on Japan - Market size and forecast 2022-2027 ($ million)
• Exhibit 101: Chart on Japan - Year-over-year growth 2022-2027 (%)
• Exhibit 102: Data Table on Japan - Year-over-year growth 2022-2027 (%)

• 9.10 Germany - Market size and forecast 2022-2027 
• Exhibit 103: Chart on Germany - Market size and forecast 2022-2027 ($ million)
• Exhibit 104: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
• Exhibit 105: Chart on Germany - Year-over-year growth 2022-2027 (%)
• Exhibit 106: Data Table on Germany - Year-over-year growth 2022-2027 (%)

• 9.11 France - Market size and forecast 2022-2027 
• Exhibit 107: Chart on France - Market size and forecast 2022-2027 ($ million)
• Exhibit 108: Data Table on France - Market size and forecast 2022-2027 ($ million)
• Exhibit 109: Chart on France - Year-over-year growth 2022-2027 (%)
• Exhibit 110: Data Table on France - Year-over-year growth 2022-2027 (%)

• 9.12 Market opportunity by geography 
• Exhibit 111: Market opportunity by geography ($ million)
• Exhibit 112: Data Tables on Market opportunity by geography ($ million)

10 Drivers, Challenges, and Trends

• 10.1 Market drivers

• 10.2 Market challenges

• 10.3 Impact of drivers and challenges 
• Exhibit 113: Impact of drivers and challenges in 2022 and 2027

• 10.4 Market trends

11 Vendor Landscape

• 11.1 Overview

• 11.2 Vendor landscape
• Exhibit 114: Overview on Criticality of inputs and Factors of differentiation

• 11.3 Landscape disruption
• Exhibit 115: Overview on factors of disruption

• 11.4 Industry risks
• Exhibit 116: Impact of key risks on business

12 Vendor Analysis

• 12.1 Vendors covered
• Exhibit 117: Vendors covered

• 12.2 Market positioning of vendors 
• Exhibit 118: Matrix on vendor position and classification

• 12.3 Abbott Laboratories
• Exhibit 119: Abbott Laboratories - Overview
• Exhibit 120: Abbott Laboratories - Business segments
• Exhibit 121: Abbott Laboratories - Key news
• Exhibit 122: Abbott Laboratories - Key offerings
• Exhibit 123: Abbott Laboratories - Segment focus

• 12.4 AbbVie Inc.
• Exhibit 124: AbbVie Inc. - Overview
• Exhibit 125: AbbVie Inc. - Product / Service
• Exhibit 126: AbbVie Inc. - Key news
• Exhibit 127: AbbVie Inc. - Key offerings

• 12.5 Bausch Health Co. Inc. 
• Exhibit 128: Bausch Health Co. Inc. - Overview
• Exhibit 129: Bausch Health Co. Inc. - Business segments
• Exhibit 130: Bausch Health Co. Inc. - Key news
• Exhibit 131: Bausch Health Co. Inc. - Key offerings
• Exhibit 132: Bausch Health Co. Inc. - Segment focus

• 12.6 Bayer AG
• Exhibit 133: Bayer AG - Overview
• Exhibit 134: Bayer AG - Business segments
• Exhibit 135: Bayer AG - Key news
• Exhibit 136: Bayer AG - Key offerings
• Exhibit 137: Bayer AG - Segment focus

• 12.7 Boehringer Ingelheim International GmbH 
• Exhibit 138: Boehringer Ingelheim International GmbH - Overview
• Exhibit 139: Boehringer Ingelheim International GmbH - Business segments
• Exhibit 140: Boehringer Ingelheim International GmbH - Key news
• Exhibit 141: Boehringer Ingelheim International GmbH - Key offerings
• Exhibit 142: Boehringer Ingelheim International GmbH - Segment focus

• 12.8 Cipla Ltd.
• Exhibit 143: Cipla Ltd. - Overview
• Exhibit 144: Cipla Ltd. - Business segments
• Exhibit 145: Cipla Ltd. - Key news
• Exhibit 146: Cipla Ltd. - Key offerings
• Exhibit 147: Cipla Ltd. - Segment focus

• 12.9 Dr Reddys Laboratories Ltd. 
• Exhibit 148: Dr Reddys Laboratories Ltd. - Overview
• Exhibit 149: Dr Reddys Laboratories Ltd. - Business segments
• Exhibit 150: Dr Reddys Laboratories Ltd. - Key offerings
• Exhibit 151: Dr Reddys Laboratories Ltd. - Segment focus

• 12.10 GlaxoSmithKline Plc
• Exhibit 152: GlaxoSmithKline Plc - Overview
• Exhibit 153: GlaxoSmithKline Plc - Business segments
• Exhibit 154: GlaxoSmithKline Plc - Key news
• Exhibit 155: GlaxoSmithKline Plc - Key offerings
• Exhibit 156: GlaxoSmithKline Plc - Segment focus

• 12.11 Haleon Plc
• Exhibit 157: Haleon Plc - Overview
• Exhibit 158: Haleon Plc - Business segments
• Exhibit 159: Haleon Plc - Key offerings
• Exhibit 160: Haleon Plc - Segment focus

• 12.12 Johnson and Johnson Services Inc. 
• Exhibit 161: Johnson and Johnson Services Inc. - Overview
• Exhibit 162: Johnson and Johnson Services Inc. - Business segments
• Exhibit 163: Johnson and Johnson Services Inc. - Key news
• Exhibit 164: Johnson and Johnson Services Inc. - Key offerings
• Exhibit 165: Johnson and Johnson Services Inc. - Segment focus

• 12.13 Novartis AG
• Exhibit 166: Novartis AG - Overview
• Exhibit 167: Novartis AG - Business segments
• Exhibit 168: Novartis AG - Key offerings
• Exhibit 169: Novartis AG - Segment focus

• 12.14 Pfizer Inc.
• Exhibit 170: Pfizer Inc. - Overview
• Exhibit 171: Pfizer Inc. - Product / Service
• Exhibit 172: Pfizer Inc. - Key news
• Exhibit 173: Pfizer Inc. - Key offerings

• 12.15 Prestige Consumer Healthcare Inc. 
• Exhibit 174: Prestige Consumer Healthcare Inc. - Overview
• Exhibit 175: Prestige Consumer Healthcare Inc. - Business segments
• Exhibit 176: Prestige Consumer Healthcare Inc. - Key offerings
• Exhibit 177: Prestige Consumer Healthcare Inc. - Segment focus

• 12.16 Sanofi SA
• Exhibit 178: Sanofi SA - Overview
• Exhibit 179: Sanofi SA - Business segments
• Exhibit 180: Sanofi SA - Key news
• Exhibit 181: Sanofi SA - Key offerings
• Exhibit 182: Sanofi SA - Segment focus

• 12.17 Takeda Pharmaceutical Co. Ltd. 
• Exhibit 183: Takeda Pharmaceutical Co. Ltd. - Overview
• Exhibit 184: Takeda Pharmaceutical Co. Ltd. - Product / Service
• Exhibit 185: Takeda Pharmaceutical Co. Ltd. - Key news
• Exhibit 186: Takeda Pharmaceutical Co. Ltd. - Key offerings

13 Appendix

• 13.1 Scope of the report

• 13.2 Inclusions and exclusions checklist 
• Exhibit 187: Inclusions checklist
• Exhibit 188: Exclusions checklist

• 13.3 Currency conversion rates for US$ 
• Exhibit 189: Currency conversion rates for US$

• 13.4 Research methodology
• Exhibit 190: Research methodology
• Exhibit 191: Validation techniques employed for market sizing
• Exhibit 192: Information sources

• 13.5 List of abbreviations
• Exhibit 193: List of abbreviations

About Us
Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provide actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

Contact
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: [email protected]
Website: www.technavio.com

SOURCE Technavio